A simplified function-first method for the discovery and optimization of bispecific immune engaging antibodies.
Bi-specific T-cell engager antibodies (BiTEs) are synthetic fusion molecules that combine multiple antibody-binding domains to induce active contact between T-cells and antigen expressing cells in the body. Blinatumomab, a CD19-CD3 BiTE is now a widely used therapy for relapsed B-cell malignancies,...
| الحاوية / القاعدة: | PLoS ONE |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Public Library of Science (PLoS)
2023-01-01
|
| الوصول للمادة أونلاين: | https://doi.org/10.1371/journal.pone.0273884 |